Filing Flows › Codexis (CDXS) › Q1 2026 › vs Q1 2025
Codexis (CDXS) Q1 2026 vs Q1 2025 (year over year)
Codexis's revenue rose $7.7M (+102%) from $7.5M in Q1 2025 to $15.2M in Q1 2026. The biggest changes: Research and development revenue +$6.6M (+443%); Product revenue +$1.1M (+19%).
Codexis, Q1 2026: revenue $15.2M (+102% year over year), operating margin -52.7%, net loss $8.7M, operating cash flow −$13.2M. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Research and development revenue | $8.1M | $1.5M | $6.6M | +443% |
| Product revenue | $7.2M | $6.1M | $1.1M | +19% |
| Revenue | $15.2M | $7.5M | $7.7M | +102% |
| Net loss | $8.7M | $20.7M | −$12.0M | -58% |
| Costs & expenses | $24.0M | $28.2M | −$4.3M | -15% |
| Operating costs | $23.3M | $28.0M | −$4.7M | -17% |
| Interest & other, net | $625K | $191K | $434K | +227% |
| Income tax | $36K | $11K | $25K | +227% |
| Cost of revenue | $2.1M | $2.7M | −$668K | -24% |
| Research & development | $11.4M | $12.9M | −$1.5M | -12% |
| SG&A | $9.8M | $12.4M | −$2.6M | -21% |
| Operating cash sources | $15.9M | $17.4M | −$1.5M | -9% |
| Depreciation & amortization | $1.3M | $1.2M | $91K | +8% |
| Share-based compensation | $1.4M | $2.4M | −$951K | -40% |
| Cash used in operations | $13.2M | $13.8M | −$648K | -5% |
| Net loss absorbed | $8.7M | $20.7M | −$12.0M | -58% |
| Working capital & other | $7.2M | −$3.3M | $10.5M | — |
Questions
How much did Codexis's revenue grow year over year in Q1 2026?
Codexis's revenue rose $7.7M (+102%) from $7.5M in Q1 2025 to $15.2M in Q1 2026.
What drove Codexis's revenue change in Q1 2026?
Research and development revenue +$6.6M (+443%); Product revenue +$1.1M (+19%).